Sm-p80-based DNA vaccine made in a human use approved vector VR1020 protects against challenge infection with Schistosoma mansoni in mouse

Parasite Immunology

Volumn 32, Issue 4, 2010, Pages 252-258

  Zhang, W ^a   Ahmad, G ^a   Torben, W ^a   Siddiqui, Afzal A ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Calpain; DNA vaccine; Schistosoma mansoni; Sm p80; Vaccine

Indexed keywords

COMPLEMENTARY DNA; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 14; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 19; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 20; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; PLASMID DNA; SCHISTOSOMA VACCINE; SM P80 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG EFFICACY; DRUG FORMULATION; FEMALE; INTESTINE INFECTION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SEROLOGY; SPLEEN CELL; TH1 CELL; TH17 CELL; TH2 CELL; TREATMENT RESPONSE; WORM INFECTION;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; CELL PROLIFERATION; CYTOKINES; FEMALE; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED C57BL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SPLEEN; VACCINES, DNA;

ANIMALIA; MURINAE; SCHISTOSOMA MANSONI;

EID: 77949452570     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2009.01181.x     Document Type: Article

References (37)

1. Berriman M, Haas BJ, LoVerde PT, et al. The genome of the blood fluke Schistosoma mansoni. Nature 2009; 460: 352-358.
2. Hotez PJ, Molyneux DH, Fenwick A, et al. Control of neglected tropical diseases. N Engl J Med 2007; 357: 1018-1027.
3. Steinmann P, Keiser J, Bos R, Tanner M & Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 2006; 6: 411-425.
4. Young BW & Podesta RB. Complement and 5-HT increase phosphatidylcholine incorporation into the outer bilayers of Schistosoma mansoni. J Parasitol 1986; 72: 802-803.
5. Ahmad G, Torben W, Zang W, Matt W & Siddiqui AA. Sm-p80 based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni. Parasite Immunol 2009; 31: 156-161.
6. Hota-Mitchell S, Siddiqui AA, Dekaban GA, Smith J, Tognon C & Podesta RB. Protection against Schistosoma mansoni infection with a recombinant baculovirus-expressed subunit of calpain. Vaccine 1997; 15: 1631-1640.
7. Hota-Mitchell S, Clarke MW, Podesta RB & Dekaban GA. Recombinant vaccinia viruses and gene gun vectors expressing the large subunit of Schistosoma mansoni calpain used in a murine immunization-challenge model. Vaccine 1999; 17: 1338-1354.
8. Siddiqui AA, Phillips T, Charest H, et al. Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation. Vaccine 2003; 20: 2882-2889.
9. Siddiqui AA, Pinkston JR, Quinlin ML, et al. Characterization of protective immunity induced against Schistosoma mansoni via DNA priming with the large subunit of calpain (Sm-p80) in the presence of genetic adjuvants. Parasite 2005; 12: 3-8.
10. Ridi RE & Tallima H. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis. Vaccine 2009; 29: 666-673.
11. Jankovic D, Aslund L, Oswald IP, et al. Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoni. J Immunol 1996; 157: 806-814.
12. Ohta N, Kumagai T, Maruyama H, Yoshida A, He Y & Zhang R. Research on calpain of Schistosoma japonicum as a vaccine candidate. Parasitol Int 2004; 53: 175-181.
13. Zhang R, Yoshida A, Kumagai T, et al. Vaccination with calpain induces a Th1-biased protective immune response against Schistosoma japonicum. Infect Immun 2001; 69: 386-391.
14. Siddiqui AA, Zhou Y, Podesta RB, et al. Characterization of Ca(2+)-dependent neutral protease (calpain) from human blood flukes, Schistosoma mansoni. Biochim Biophys Acta 1993; 24: 37-44.
15. Karcz SR, Podesta RB, Siddiqui AA, Dekaban GA, Strejan GH & Clarke MW. Molecular cloning and sequence analysis of a calcium-activated neutral protease (calpain) from Schistosoma mansoni. Mol Biochem Parasitol 1991; 49: 333-336.
16. Siddiqui AA, Ahmad G, Damian RT & Kennedy RC. Experimental vaccines in animal models for schistosomiasis. Parasitol Res 2008; 102: 825-833.
17. Siddiqui AA, Phillips T, Charest H, et al. Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte- macrophage colony-stimulating factor and interleukin-4. Infect Immun 2003; 71: 3844-3851.
18. Siddiqui AA, Pinkston JR, Quinlin ML, et al. Characterization of the immune response to DNA vaccination strategies for schistosomiasis candidate antigen, Sm-p80 in the baboon. Vaccine 2005; 23: 1451-1456.
19. Smith JK, Siddiqui AA, Modica LA, et al. Interferon-alpha upregulates gene expression of aquaporin-5 in human parotid glands. J Interferon Cytokine Res 1999; 19: 929-935.
20. Brandt K, Bulfone-Paus S, Foster DC, et al. Interlukin-21 inhibits dendritic cell activation and maturation. Blood 2003; 102: 4090-4098.
21. Godinez I, Haneda T, Raffatellu M, et al. T cells help to amplify inflammatory responses induced by Salmonella enterica serotype typhimurium in the intestinal mucosa. Infect Immun 2008; 76: 2008-2017.
22. Lauwerys BR, Garot N, Renauld JC, et al. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or a combination of IL-12and Il-18. J Immunol 2000; 165: 1847-1853.
23. Montgomery RA & Dallman MJ. Analysis of cytokine gene expression during fetal thymic ontogeny using the polymerase chain reaction. J Immunol 1991; 147: 554-560.
24. Ren F, Xhan X, Martens G, et al. Pro-IL-16 regulation in activated murine CD4+ lymphocytes. J Immunol 2005; 174: 2738-2745.
25. Shen L, Zhang C, Wang T, et al. Development of autoimmunity in IL-14 alpha-transgenic mice. J Immunol 2006; 177: 5676-5686.
26. McManus DP & Loukas A. Current status for schistosomiasis. Clin Microbiol Rev 2008; 21: 225-242.
27. Capron A, Riveau G, Capron M & Trottein F. Schistosomes: the road from host-parasitic interactions to vaccines in clinical trials. Trends Parasitol 2005; 21: 143-149.
28. Lebens M, Sun JB, Czerkinsky C & Holmgren J. Current status and future prospects for a vaccine against schistosomiasis. Expert Rev Vaccines 2004; 3: 315-328.
29. Pearce EJ. Progress towards a vaccine for schistosomiasis. Acta Trop 2003; 86: 309-313.
30. Ahmad G, Zhang W, Torben W, Damian RT, et al. Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model. Vaccine 2009; 27: 2830-2837.
31. Cardoso FC, Macedo GC, Gava E, et al. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1 type of immune response and protection against parasite infection. PLoS Negl Trop Dis 2008; 2(10): e308. Doi: 10.1371/journal.pntd. 0000308.
32. Arend WP, Palmer G & Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008; 223: 20-38.
33. Ward PA. The curiosity of IL-15. Nat Med 2007; 13: 903-904.
34. Tallima H, Salah M, Guirguis FR & El Ridi R. Transforming growth factor-b and Th17 responses in resistance to primary murine schistosomiasis mansoni. Cytokine 2009; 48: 239-245.
35. Bettelli E, Korn T, Oukka M & Kuchroo VK. Induction and effector functions of T (H) 17 cells. Nature 2008; 453: 1051-1057.
36. McGeachy MJ & Cua DJ. Th17 cell differentiation: the long and winding road. Immunity 2008; 28: 445-453.
37. Dong C. Th17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8: 337-348.